Hockenhull, Joanna http://orcid.org/0000-0002-3361-7598
Wood, David M.
Fonseca, Francina
Guareschi, Marilena
Scherbaum, Norbert
Iwanicki, Janetta L.
Dart, Richard C.
Dargan, Paul I.
Article History
Received: 18 August 2020
Accepted: 11 May 2021
First Online: 4 March 2022
Declaration
:
: The survey was approved by the Colorado Multiple Institutional Review Board (Protocol Number: 13–2394).
: PD and DW have acted as scientific advisors to the UK Advisory Council on the Misuse of Drugs (ACMD) and the European Monitoring Centre for Drugs and Drug Abuse (EMCDDA). NS has received honoraria for several activities (e.g. advisory board membership, lectures, manuscripts) from AbbVie, Camurus, Hexal, Janssen-Cilag, MSD, Medice, Mundipharma, Reckitt-Benckiser/Indivior and Sanofi-Aventis. During the last 3 years, he has participated in clinical trials financed by the pharmaceutical industry. All other authors declare no conflict of interest.